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MATERIALS AND METHODS

Animals.
All animal experiments conformed to the "Guide for the Care and Use of Laboratory Animals" published by the National Institutes of Health (NIH Publication No. 85-23, Revised 1996) and the Danish national guidelines. The mice were housed at the Biomedical Laboratory, University of Southern Denmark and kept on a 12:12 h light-dark cycle at a controlled temperature (21 Ϯ 1°C) and with free access to standard pathogen-free chow (Altromin, Lage, Germany) and tap water.
Studies were conducted in male (n ϭ 21) and female (n ϭ 18) COX-2 Ϫ/Ϫ and COX-2 ϩ/ϩ mice (20 -25 g) at 8 -9 wk of age. The mice were originally developed by Dinchuk et al. (4) , and heterozygous breeding pairs were obtained from Jackson Laboratories (strain name; B6;129S-Ptgs2 tm1Jed /J) on a predominant C57BL6 genetic background and further backcrossed for nine generations (C57BL6) before experiments. Genotyping was performed with DNA from tail biopsies as described (8) using a REDExtract-NAmp tissue PCR kit (Sigma-Aldrich, Copenhagen, Denmark).
Salt diet. Mice were divided into four groups: group I: COX-2 ϩ/ϩ , low-salt (LS) diet (0.004% NaCl); group II: COX-2 ϩ/ϩ , high-salt (HS) (4% NaCl); group III: COX-2 Ϫ/Ϫ , LS diet (0.004% NaCl); and group IV: COX-2 Ϫ/Ϫ , HS diet (4% NaCl). The LS diet (0.004%) was purchased from Ziegler Bros (Gardners, PA) and grinded into powder. To obtain HS diet, 4% NaCl was added. The NaCl content was confirmed by flame photometry of supernatants. The mice were fed either a HS or a LS diet for 8 days before surgery and throughout the blood pressure measurements, for a total of 17 days.
Arterial blood pressure measurement. The mice were anesthetized with an intraperitoneal injection of ketamine (50 mg/kg) and xylazine (10 mg/kg), and supplementation was given during surgery if needed. A catheter was placed in the femoral artery for the measurement of arterial blood pressure and heart rate, as described (33) . After surgery, the catheter was attached to a swivel (Instech Laboratories, Plymouth Meeting, PA) so that the mice were able to move freely in their cage. They were allowed to recover for 5 days after operation, during which period the arterial catheters were kept open with infusion of 10 l/h heparin solution (100 units in glucose). Before the experiment the arterial line was connected to a pressure transducer (Föhr Medical Instruments, Hesen, Germany), and data were collected at 200 Hz using Lab View software (National Instruments, Austin, TX). Systolic and diastolic blood pressures together with heart rate were measured continuously for 4 days (days 14 -17) . Mean values for every 5 min were generated and mean values for day (light period) and night (dark period) were calculated. The diurnal variation in blood pressure and heart rate in the four groups was expressed as the mean difference between dark and light period. At the end of the experiment a blood sample (ϳ200 l) was collected. The mice were anesthetized by an infusion of pentobarbital and then euthanized, and kidneys and aortas were harvested. The kidneys were divided into cortex and medulla and tissues were stored at Ϫ80°C until further analysis.
A separate group of mice [COX-2 Ϫ/Ϫ and wild-type (C57BL6), 6 wk of age] on normal salt diet were anesthetized and then euthanized, and hearts were harvested for determination of the heart-to-body weight ratio.
Metabolic cages. In separate experiments, mice were divided into four groups (I, II, III, IV). Each group received either a HS or a LS diet for 12 days before the experiment, allowing the mice to achieve a sodium balance in steady state. Mice were then placed in individual metabolic cages for 5 days, and the original salt diet continued until the end of the experiment. After a 3-day run-in period, body weight, food and water intake, and urine excretion were measured for 2 consecutive days. The urine from days 13 to 15 was discarded but the 24-h urine samples of days 16 and 17 (corresponding to the last days of blood pressure measurement) were collected. At the end of the experiment a blood sample was taken.
Plasma and urine analysis. Urine osmolality was determined by freeze-point depression (Osmomat 030-D, Gonotec, Bie and Berntsen, Herlev, Denmark). Na and K concentrations were determined by flame photometry (model IL 943, Instrumentation Laboratory, Lexington, MA). The plasma renin concentration was measured by radioimmunoassay as described (26) .
Urine and plasma NOx were determined using a Nitrate/Nitrite Colorimetric Assay Kit (780001, Cayman Chemical, Aarhus, Denmark). Nitrate was converted to nitrite utilizing nitrate reductase, followed by the addition of Griess Reagents converting nitrite into a deep purple azo compound. Samples were diluted 1:5 (urine) and 1:2 (plasma) and run in duplicate. Urine (unacetylated, diluted 1:500) and plasma (acetylated, diluted 1:2,500) cGMP were measured using enzyme immunoassay kits (581001, Cayman Chemical). Urine cAMP was measured using enzyme immunoassay kits (581021, Cayman Chemical). Samples were unacetylated, diluted 1:500, and run in duplicate.
Prostanoids were extracted from 100-l plasma samples and amounts were determined by LC/MS-MS as described (29) . In brief, for liquid-liquid extraction, samples were incubated twice with 600 l ethylacetate, and the organic phase was removed at 45°C under nitrogen. For reconstitution 50 l of acetonitrile-water-formic acid (20:80:0.0025, vol/vol, pH 4.0) were used, and after centrifugation for 5 min at 18,000 g samples were used for injection. Prostanoids were separated with a Synergi 150 ϫ 2 mm Hydro-RP column (Phenomenex, Aschaffenburg, Germany) and determined with an API 4000 triple quadrupole mass spectrometer (AB Sciex, Darmstadt, Germany).
Polymerase chain reaction. Messenger RNA was isolated by phase separation from whole aortas and kidney cortex and medulla using TRIzol Reagent. The RNA was quantified by spectrophotometry and stored at Ϫ80°C. cDNA was made using the iScript cDNA Synthesis Kit (Bio-Rad, Copenhagen, Denmark). Quantitative PCR was performed with primer sets shown in Table 1 using 50 ng cDNA in duplicate mixed with iQ SYBR Green Supermix (Bio-Rad). Water and samples without reverse transcriptase were used as negative controls. The mixture was denatured for 3 min at 95°C, and 44 cycles were run on a Stratagene Mx3000 (AH Diagnostics, Aarhus, Denmark) as follows: denaturation at 95°C for 30 s, and annealing and extension, 45 s at 60°C [40 cycles, 95°C for 20 s and 60°C for 20 s for atrial natriuretic peptide (ANP)]. A melting curve analysis confirmed specificity postrun for each plate setup, and a standard curve was constructed by plotting threshold cycle (C t values) against serial dilutions. Purified PCR product was used to generate a standard curve.
Western blotting. Kidney medulla samples were homogenized in ice-cold sucrose-imidazole buffer containing 0.3 M sucrose, 25 mM imidazole, 1 mM EDTA-disodium salt, 0.4 M Pefabloc, 2.1 mM leupeptin, 1 mM Na-ortho-vanadate, 0.2 M NaF, and 0.082 g/l okadaic acid. Protein concentrations were determined using the Bradford Protein Assay (Bio-Rad). Table 1 . Primer sequences
Sequences of DNA oligo primers used in PCR analyses. eNOS, endothelial nitric oxide synthase (NOS); iNOS, inducible NOS; nNOS, neuronal NOS, COX-2, cyclooxygenase-2; ANP, atrial natriuretic peptide; Tbcc, tubulin folding cofactor C.
Thirty micrograms of protein were separated by SDS-PAGE (4 -15% Tris·HCl gels, Bio-Rad) and transferred to a 0.45-m pore-size Immobilin-P PVDF-membrane (Millipore, Copenhagen, Denmark) using the XCell SureLock Mini-Cell system (Invitrogen, Naerum, Denmark). Membranes were blocked with 5% nonfat milk in TBST [20 mM Tris-base (Sigma), 137 nM NaCl, 0.05% Tween 20 (Sigma), pH 7.6] for 1 h under gentle shaking. Membrane were then incubated with primary antibody; rabbit polyclonal to eNOS (ab5589, Abcam, Cambridge, UK) or rabbit monoclonal to phospho-eNOS (Thr495) (05-811, Upstate) diluted 1:1,000 and 1:500 respectively in 5% milk in TBST and incubated overnight at 4°C. This was followed by incubation with a horseradish peroxidase-conjugated secondary antibody directed against rabbit IgG (diluted 1:2,000, goat anti-rabbit, P0448, Dako, Glostrup, Denmark) for 1 h at RT. Labelling was visualized by the ECL plus Western Blotting Detection System (Amersham Biosciences/GE Healthcare, Munich, Germany). Optical densities of the bands were determined with Quantity One 4.03 software (Bio-Rad). To confirm equal protein loading membranes were stripped (TBST, pH 2) 2 ϫ 10 min, blocked, and loaded with an antibody against ␤-actin (1:2,000, Abcam, Cambridge, UK).
Statistical evaluation. Blood pressure and heart rate data were integrated over 12-h periods (light:dark periods) for days 14 to 17 and mean values for each group were calculated. Data were classified within two categorical variables or factors: salt intake and genotype. Hence, two-way ANOVA was applied to determine the significance of the main effects as well as the interaction of the two factors, followed by Bonferroni post hoc test to assess the difference between groups. Specifically, changes in mean values of blood pressure and heart rate were compared by two-way ANOVA followed by Bonferroni's multiple comparison test. Delta values of blood pressure (difference between night and day) were calculated and analyzed by two-way ANOVA followed by post hoc analysis with Bonferroni's multiple comparison test. Data for metabolic parameters and expression levels of specific mRNA and protein molecules were analyzed by two-way ANOVA followed by post hoc analysis with Bonferroni correction. P values for interaction, genotype, and diet are reported for each data set in the legends to figures, and significance from the Bonferroni multiple comparison post hoc analysis is indicated with an asterisk. P values Ͻ0.05 were considered to indicate statistically significant differences.
RESULTS
Arterial blood pressure and heart rate. Mean arterial blood pressure (MAP) was increased significantly by the high-salt diet in COX-2 ϩ/ϩ (Fig. 1A) , during both the light and dark phases, and in COX-2 Ϫ/Ϫ mice only during the dark phase (Fig. 1B) , in the 4 days recording period. Heart rate was not significantly different between groups at any time during the 4 days (Fig. 1C) . A higher arterial blood pressure was observed in COX-2 Ϫ/Ϫ mice compared with COX-2 ϩ/ϩ mice at both levels of salt intake primarily during the dark (active) phase (Fig. 1, D and E) . MAP, averaged over the whole recording period, was increased by high-salt diet in both genotypes and was significantly higher in the COX-2 Ϫ/Ϫ mice at both levels of NaCl intake compared with COX-2 ϩ/ϩ littermate controls (Fig. 1F) . COX-2 Ϫ/Ϫ at high NaCl intake displayed highest MAP value (Fig. 1F) .
MAP was significantly elevated in the dark phase (night-"N") in all groups ( Fig. 2A) , and the difference in MAP (⌬) between night and day was significantly augmented by high salt intake in both genotypes (Fig. 2B ) (interaction genotype ϫ diet; P ϭ 0.01). The difference in MAP between night and day was significantly higher in COX-2 Ϫ/Ϫ on high-salt diet compared with all other groups (Fig. 2B) . The heart-to-body weight ratio was significantly higher in adult COX-2 Ϫ/Ϫ mice (0.64 Ϯ 0.05 g, n ϭ 7) on continuous normal salt diet compared with wild-type mice (0.49 Ϯ 0.01 g, n ϭ 8) on normal salt diet (data not shown). No significant difference in MAP was observed between male and female mice in any of the categories genotype and salt intake (Fig. 2, C-F) .
Effect of salt intake on diuresis, urine osmolality, urine K ϩ and Na ϩ excretion, plasma renin and 6-keto-PGF 1␣ concentrations. The mean food intake (days 16 and 17, when urine was collected) was not different between groups: COX-2 ϩ/ϩ (LS; 3.96 Ϯ 0.23, HS; 3.85 Ϯ 0.30) and COX-2 Ϫ/Ϫ (LS; 3.57 Ϯ 0.28, HS; 3.47 Ϯ 0.11) g/day. Water intake was significantly elevated with a high-salt diet in COX-2 Ϫ/Ϫ and COX-2 ϩ/ϩ mice (Fig. 3A) . Diuresis was larger in mice with a high NaCl intake and not different between genotypes (Fig. 3B) . Urine K ϩ excretion was not different between groups (interaction genotype ϫ diet; P ϭ 0.04), whereas Na ϩ excretion was significantly elevated on high-salt diet (Fig. 3, C and D) . On a low-salt diet, urine osmolality was significantly lower in COX-2 Ϫ/Ϫ compared with COX-2 ϩ/ϩ (763 Ϯ 39 and 2,158 Ϯ 184 mosmol/kg H 2 O, respectively). A high-salt diet caused a lower urine osmolality compared with low-salt diet in COX-2 ϩ/ϩ (1,538 Ϯ 90 and 2,158 Ϯ 184 mosmol/kg H 2 O, respectively), whereas urine osmolality was not significantly changed with salt intake in COX-2 Ϫ/Ϫ mice [763 Ϯ 39 (LS) and 1,379 Ϯ 182 (HS) mosmol/kg H 2 O, respectively]. Total osmolal excretion was significantly higher with a high NaCl intake and not different between genotypes (Fig. 3E) . With low-salt diet, plasma renin concentration increased compared with high NaCl in both genotypes. At low NaCl intake, COX-2 Ϫ/Ϫ mice exhibited a lower plasma renin concentration compared with COX-2 ϩ/ϩ (Fig. 3F) . There was no significant difference in plasma renin concentration between genotypes after a high NaCl intake ( 
. Effect of HS and LS diet (HS, 4%
NaCl and LS, 0.004% NaCl, 18 days) on diurnal variation in MAP and MAP data separated by sex in conscious, freely moving COX-2 Ϫ/Ϫ and COX-2 ϩ/ϩ mice. A: MAP averaged for all day and night recordings during the whole period of observation (day 14-night 17, postsurgery) in COX-2 ϩ/ϩ and COX-2 Ϫ/Ϫ mice on HS and LS diet. B: difference in MAP between day and night (diurnal variation) averaged from days 14 to 17 in COX-2 ϩ/ϩ and COX-2 Ϫ/Ϫ mice on HS and LS diet. C: MAP averaged for night and day between male (n ϭ 6) and female (n ϭ 4) COX-2 ϩ/ϩ mice on LS diet. D: average MAP for male (n ϭ 6) and female (n ϭ 5) COX-2 ϩ/ϩ mice on HS diet. E: average night and day MAP for male (n ϭ 4) and female (n ϭ 4) COX-2 Ϫ/Ϫ mice on LS diet. F: average night and day MAP in male (n ϭ 5) and female (n ϭ 5) COX-2 Ϫ/Ϫ mice on HS diet. Bar graphs depict means Ϯ SE. There were no differences in blood pressure between male and female mice of either genotype. Statistical evaluation was performed by twoway ANOVA followed by Bonferroni post hoc test. *Statistically significant difference between groups at P Ͻ 0.05 (Bonferroni multiple comparison post hoc test). P values for interaction (I), genotype (G), and diet (D) for B: I, 0.01; G, P Ͻ 0.0001; and D, P Ͻ 0.0001.
COX-2
ϩ/ϩ : 0.55 Ϯ 0.16 ng/ml) was not changed significantly by either salt diet or genotype.
Plasma and urinary excretion of NOx, cGMP, cAMP, and ANP mRNA expression. Urine NOx and cGMP excretions were elevated significantly and to a similar extent in COX-2 Ϫ/Ϫ and COX-2 ϩ/ϩ on high-salt diet (Fig. 4 , A and B) (NOx interaction genotype ϫ diet; P Ͻ 0.0001), whereas high-salt diet did not affect plasma NOx and cGMP concentration significantly (Fig.  4, C and D) . The urine excretion of cAMP was significantly elevated in COX-2 ϩ/ϩ by the high-salt diet. In mice fed the low-salt diet, it was significantly increased in COX-2 Ϫ/Ϫ compared with COX-2 ϩ/ϩ . In COX-2 Ϫ/Ϫ the high-salt diet did not affect cAMP urine excretion significantly (Fig. 4E ) (interaction genotype ϫ diet; P ϭ 0.0002). High-salt diet did not affect the level of ANP mRNA in the heart (left ventricle) significantly (Fig. 4F) .
Renal and vascular expression of NOS isoforms and COX-2. High-salt diet did not cause significant changes in mRNA levels of eNOS or iNOS in the medulla, cortex, or aorta (Table 2) . nNOS mRNA level was elevated significantly in the kidney cortex of COX-2 Ϫ/Ϫ independently of salt diet compared with wild-type mice (Fig. 5B , nNOS primers covered a region that is conserved in the multiple known splice variants), whereas no other significant changes in nNOS were observed in kidney medulla and aorta (Fig. 5, A and C ). COX-2 mRNA level was not changed in the kidney medulla (Fig. 5D ), but it was significantly reduced by a high-salt diet in the kidney cortex and aorta of wild-type littermates (Fig. 5, E and F) . COX-2 was not amplified with cDNA template from COX-2 Ϫ/Ϫ mice. The abundance of total eNOS and of phospho-Thr495-eNOS proteins in the kidney medulla was not affected by either salt diet or genotype (Fig. 5, G and H) .
DISCUSSION
The major findings of the present study are the following: 1) Global COX-2 deletion in mice on a C57BL6 background results in a significant elevation of arterial blood pressure, irrespective of salt intake and plasma prostacyclin; 2) C57BL6 mice display NaCl-sensitive blood pressure; 3) a specific "NaCl sensitivity" of arterial blood pressure associated with COX-2 was observed during dark periods (which corresponds to the awake, active period), where chronic salt intake caused a larger increase in arterial blood pressure in COX-2 Ϫ/Ϫ ; 4) differences in arterial blood pressure presumably reflect changes in peripheral resistance as the diurnal changes in heart rate were comparable in the different experimental groups; 5) There were no differences in blood pressure between male and female mice in any group; and 6) COX-2 activity does not drive renal medullary NO synthesis.
Thus COX-2 activity protects against increases in arterial blood pressure and in particular attenuates an increase in blood pressure associated with the active awake phase of the mice (darkness) during chronic high salt intake. This was reflected by cardiac hypertrophy in adult COX-2 Ϫ/Ϫ mice. In mechanistic terms, the high-salt diet had no effect on medullary eNOS synthase mRNA level and protein abundance, whereas surrogate markers for renal NO production increased to a similar degree in both genotypes as judged by the augmented nitrite and cGMP excretions. Since plasma levels of NOx and cGMP and cardiac ANP expression were not altered, the marked increase in urinary excretions of NOx and cGMP most likely reflects local, renal NO synthesis. COX-2 Ϫ/Ϫ mice exhibited no systemic indices of prostacyclin deficiency, and COX-2 activity therefore does not appear necessary for systemic formation of this prostanoid and for the NaCl-induced stimulation of NO production in the renal medulla. The present findings also imply that, in the normal mouse, at the systemic level, if chronic salt intake increases the availability of arachidonic acid, the fatty acid is likely to be metabolized primarily through COX-1.
The increase in urinary cAMP excretion caused by chronic salt loading observed in wild-type mice was absent in COX-2 Ϫ/Ϫ mice. The cAMP excretion in COX-2 Ϫ/Ϫ mice on low salt was higher compared with COX-2 ϩ/ϩ on low salt. COX-2 Ϫ/Ϫ have elevated vasopressin expression already at baseline (25) , which may account for the present lack of reactivity of cAMP to the stimulation of elevated NaCl.
Despite homeostatic suppression of renin and natriuresis, an increased dietary NaCl intake precipitated hypertension in Values are means Ϯ SE. Messenger RNA levels for eNOS and iNOS in kidney medulla, cortex, and aorta as measured by qRT-PCR in tissues from COX-2
and COX-2 ϩ/ϩ mice on high-(4%) and low-(0.004%) salt diet (n ϭ 6 -8 in each group). Tissue was harvested from mice on day 18 of salt diet. Messenger RNA levels are shown relative to GAPDH.
wild-type C57BL6 mice, as observed previously (6) , and as observed in mice with disruption of eNOS, COX-1, IP, and EP2 receptors, and mPGES-1 Ϫ/Ϫ (7, 14, 17, 19) . IP, EP2, and EP4 receptors are Gs-coupled adenylyl cyclase-activating receptors associated with the vasa recta, the medullary collecting ducts, and the descending limb of the loop of Henle. Because PGE 2 appears to drive NO synthesis in the medulla (14) , because prostacyclin and PGE 2 cause vasodilatation by activating eNOS (11, 31) , and because local inhibition of NO synthase and COX-2 in the renal medulla increase blood pressure in response to high salt, a serial coupling may exist between NaCl-sensitive renomedullary COX-2 activity and renal NO synthesis by eNOS. The present results demonstrate that COX-2 expression in the mouse renal medulla of C57BL6 mice does not display the same direct correlation with salt intake as observed in, for example, the rat kidney medulla (12, 39) , and that COX-2 deletion does not decrease the abundance of eNOS mRNA and protein. The overall renomedullary NO production, to judge from the increased urine NOx and cGMP excretions, increased in response to chronic high NaCl in a 
Kidney Medulla
Kidney Cortex Aorta Fig. 5 . Messenger RNA levels for neuronal nitric oxide synthase (nNOS) in kidney medulla (A), kidney cortex (B), and aorta (C) and for COX-2 in kidney medulla (D), kidney cortex (E), and aorta (F) as measured by RT-qPCR in tissues from COX-2 Ϫ/Ϫ and COX-2 ϩ/ϩ mice on HS (4%) and LS (0.004%) diet (n ϭ 6 -8 in each group). Tissues were harvested from mice with chronic indwelling arterial catheters on day 18 of salt diet. Messenger RNA levels for nNOS and COX-2 are shown relative to level of GAPDH. Immunoblotting and densitometric semiquantification of protein levels of total endothelial NOS (eNOS) (G) and phospho-Thr495-eNOS (H) in kidney medulla. Tissues were harvested from mice with chronic catheters on day 18 of the salt diet (n ϭ 6 -8 for each condition). Columns show mean values Ϯ SE. Two-way ANOVA followed by Bonferroni post hoc test was applied. *Statistically significant difference between groups at P Ͻ 0.05 (Bonferroni multiple comparison post hoc test). Statistical analyses of two groups were performed with an unpaired Student's t-test. P values for interaction (I), genotype (G), and diet (D) are the following. A: I, 0.8993; G, P ϭ 0.06; and D, P ϭ 0.1. B: I, 0.6; G, P ϭ 0.002; and D, P ϭ 0.3. C: I, 0.3; G, P ϭ 0.4; and D, P ϭ 0.06. similar fashion in the presence or absence of COX-2. The statistical interaction between genotype and NaCl intake with NOx as variable suggest a complex interaction, however, that is not uncovered by the present approach. This observation then implies that the dependency on mPGES-1 activity of NO formation, unmasked in mPGES-1 Ϫ/Ϫ (14), is not at the level of COX-2. Because COX-1 is expressed at higher levels in the renal medulla of COX-2 Ϫ/Ϫ (39) and COX-1 deletion attenuated NOx excretion and increased blood pressure in mice (15), the COX-1 isoform must compensate for the loss of COX-2 and provide substrate for mPGES-1. Redundancy between COX-1 and COX-2 in the medulla with mPGES-1 as a common downstream mediator is therefore a highly likely explanation for the discrepancy between data on NO indices and cGMP excretion obtained in salt-loaded COX-1 Ϫ/Ϫ and mPGES-1 Ϫ/Ϫ mice (14) and the present results in COX-2
animals. Although COX-1 may support NO synthesis in the medulla of COX-2 Ϫ/Ϫ , the present observation that blood pressure is not protected fully by COX-1 in the absence of COX-2 when mice are challenged by high salt intake is in accord with data from mice where COX-2 was replaced globally by COX-1. This precipitated hypertension in response to increased NaCl intake (41) . A logical conclusion is that the increase in arterial blood pressure caused by chronic high salt intake in active, COX-2 Ϫ/Ϫ mice is not likely to be caused by attenuated renal NO signaling.
As originally observed (4, 24) and later confirmed (38), COX-2 Ϫ/Ϫ mice display a renal developmental defect with fewer and immature, last-generation, subcapsular, nephrons and juxtamedullary glomerular hypertrophy. This defect is less pronounced in C57BL6 mice than in mice with other genetic backgrounds (38) . Accumulation of small subcapsular glomeruli was typical and fibrosis was noted in some mice in the present study. Therefore, the elevated pressure in COX-2 Ϫ/Ϫ mice could be secondary to the kidney tissue injury. On the other hand, a COX-2 knockdown strategy in C57BL6 mice showed mild renal functional and structural injury with elevated blood urea nitrogen (BUN), similar to the present mice (30) , while telemetric blood pressure recordings showed blood pressure in adult COX-2 knockdown mice not different from COX-2 ϩ/ϩ and with no circadian variation (30) . Other murine models with a comparable minor developmental nephron deficit have an elevated arterial blood pressure (2) . Similarly, in the rat, postnatal nephron deficit induces hypertension (35) while it stimulates the renin-angiotensin system (32) . The present findings confirm that COX-2 deletion is associated with attenuated renin secretion after low salt (18, 37) , while high salt led to similar suppression. Thus the renin system reacts adequately to extra NaCl intake considering a higher blood pressure in COX-2 Ϫ/Ϫ , which indicates that the renin-angiotensin system is less likely causal for the elevated pressure. An unexpected finding of the present study was that high NaCl intake precipitates a significant elevation in blood pressure during the awake phase (darkness period), and this increase was significantly larger in COX-2 Ϫ/Ϫ compared with all other groups. However, the statistical significant interaction between genotype and salt intake with delta pressure as dependent variable suggests a complex interplay. COX-2 is expressed in the hypothalamus (25) . COX-1 Ϫ/Ϫ mice on normal salt diet also display altered diurnal variations of blood pressure. Impaired regulation of the circadian clock may contribute to cardiovascular disease (15, 28) and targeted deletion of two hypothalamic clock components results in salt-sensitive hypertension (5) . Such enhanced effect of salt on blood pressure during the awake phase is also seen in eNOS Ϫ/Ϫ mice on high-salt diet (21) .
Perspectives and Significance
The present study shows a salt intake-dependent increase in MAP ϳ10 mmHg with largest surge during the awake phase in the conventional lab mouse strain C57BL6 mice. Furthermore, the findings indicate that functional deletion of COX-2 increases blood pressure at both low and high salt intakes and that COX-2 activity attenuates particularly the rise in nocturnal blood pressure in mice chronically exposed to high salt. Chronic high NaCl intake leads to increased renal production of NO that is not dependent on COX-2. A serial coupling between COX-2 and eNOS in the renal medulla is not necessary to moderate arterial blood pressure during high NaCl intake.
COX-2 is necessary to allow blood pressure homeostasis in response to salt loading, and the effect of COX-2 does not depend on prostacyclin and NO but may involve early effects on renal development.
